CardioVascular Dynamics' Lynx catheters cleared by FDA:
This article was originally published in Clinica
Executive Summary
CardioVascular Dynamics Lynx coronary catheters have been cleared by the FDA for marketing in the US. The company can now sell eight different models of its Lynx over-the-wire catheter for the treatment of atherosclerosis. The condition blocks blood flow within coronary arteries.